Jennifer Lachey
Chief Tech/Sci/R&D Officer at KEROS THERAPEUTICS, INC.
Jennifer Lachey active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KEROS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-05-31 | - |
| Corporate Officer/Principal | 2016-06-30 | 2019-05-31 |
Career history of Jennifer Lachey
Former positions of Jennifer Lachey
| Companies | Position | Start | End |
|---|---|---|---|
| SERES THERAPEUTICS, INC. | Director/Board Member | 2015-02-28 | 2016-06-30 |
| EMBER THERAPEUTICS, INC. | Corporate Officer/Principal | 2012-06-30 | 2014-12-31 |
| ACCELERON PHARMA INC. | Corporate Officer/Principal | 2007-12-31 | 2012-06-30 |
Training of Jennifer Lachey
| Indiana University | Undergraduate Degree |
| University of Cincinnati (Ohio) | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| KEROS THERAPEUTICS, INC. | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| EMBER THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Lachey
- Experience
